Drug Profile
Research programme: nitric oxide-releasing compounds - Biolipox/NicOx
Alternative Names: NCX 1501; NCX 1512Latest Information Update: 10 Jul 2007
Price :
$50
*
At a glance
- Originator Biolipox; NicOx
- Class
- Mechanism of Action Histamine receptor antagonists; Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Allergic rhinitis; Respiratory tract disorders
Most Recent Events
- 10 Jul 2007 Discontinued - Preclinical for Allergic rhinitis in Europe (unspecified route)
- 10 Jul 2007 Discontinued - Preclinical for Respiratory tract disorders in Europe (unspecified route)
- 02 May 2006 No development reported - Preclinical for Allergic rhinitis in Europe (unspecified route)